BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29035882)

  • 1. Regulation of Arthritis Severity by the Acid Sphingomyelinase.
    Beckmann N; Becker KA; Walter S; Becker JU; Kramer M; Hessler G; Weber S; Göthert JR; Fassbender K; Gulbins E; Carpinteiro A
    Cell Physiol Biochem; 2017; 43(4):1460-1471. PubMed ID: 29035882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis.
    Walter S; Gulbins E; Halmer R; Jahromi NH; Becker KA; Schottek A; Blatti C; Davies L; Schnoeder L; Bertsch T; Engelhardt B; Fassbender K
    Neurosignals; 2019; 27(S1):20-31. PubMed ID: 31778303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
    Chami M; Halmer R; Schnoeder L; Anne Becker K; Meier C; Fassbender K; Gulbins E; Walter S
    PLoS One; 2017; 12(6):e0178622. PubMed ID: 28582448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTRP3 plays an important role in the development of collagen-induced arthritis in mice.
    Murayama MA; Kakuta S; Maruhashi T; Shimizu K; Seno A; Kubo S; Sato N; Saijo S; Hattori M; Iwakura Y
    Biochem Biophys Res Commun; 2014 Jan; 443(1):42-8. PubMed ID: 24269820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deficiency of Wnt5a diminishes disease severity in a murine model of rheumatoid arthritis.
    MacLauchlan S; Zuriaga MA; Fuster JJ; Cuda CM; Jonason J; Behzadi F; Duffen JP; Haines GK; Aprahamian T; Perlman H; Walsh K
    Arthritis Res Ther; 2017 Jul; 19(1):166. PubMed ID: 28724439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis.
    Odobasic D; Yang Y; Muljadi RC; O'Sullivan KM; Kao W; Smith M; Morand EF; Holdsworth SR
    Arthritis Rheumatol; 2014 Apr; 66(4):907-17. PubMed ID: 24757143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
    Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
    Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides.
    Ma J; Gulbins E; Edwards MJ; Caldwell CC; Fraunholz M; Becker KA
    Cell Physiol Biochem; 2017; 43(6):2170-2184. PubMed ID: 29069651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors secreted from dental pulp stem cells show multifaceted benefits for treating experimental rheumatoid arthritis.
    Ishikawa J; Takahashi N; Matsumoto T; Yoshioka Y; Yamamoto N; Nishikawa M; Hibi H; Ishigro N; Ueda M; Furukawa K; Yamamoto A
    Bone; 2016 Feb; 83():210-219. PubMed ID: 26603475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
    Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis.
    Shimizu T; Takahata M; Kameda Y; Endo T; Hamano H; Hiratsuka S; Ota M; Iwasaki N
    Bone; 2015 Oct; 79():65-70. PubMed ID: 26027508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.
    Orosa B; García S; Martínez P; González A; Gómez-Reino JJ; Conde C
    Ann Rheum Dis; 2014 Jan; 73(1):298-305. PubMed ID: 23486415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The loss of α2β1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis.
    Peters MA; Wendholt D; Strietholt S; Frank S; Pundt N; Korb-Pap A; Joosten LA; van den Berg WB; Kollias G; Eckes B; Pap T
    Arthritis Rheum; 2012 May; 64(5):1359-68. PubMed ID: 22083543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
    Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
    Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-106b attenuates inflammatory responses and joint damage in collagen-induced arthritis.
    Tao Y; Wang Z; Wang L; Shi J; Guo X; Zhou W; Wu X; Liu Y; Zhang W; Yang H; Shi Q; Xu Y; Geng D
    Rheumatology (Oxford); 2017 Oct; 56(10):1804-1813. PubMed ID: 28957555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.